Land: Australien
Sprog: engelsk
Kilde: Department of Health (Therapeutic Goods Administration)
hyoscine butylbromide, Quantity: 20 mg
Southern XP IP Pty Ltd
Hyoscine butylbromide
Injection, solution
Excipient Ingredients: water for injections; sodium chloride; hydrochloric acid; sodium hydroxide
Intravenous, Intramuscular
5, 10
(S4) Prescription Only Medicine
Spasm of the gastrointestinal tract, biliary spasm, renal spasm, diagnostic aid in radiology.
Visual Identification: Clear, colourless or almost colourless solution filled in Type I clear glass ampoules.; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2017-07-12